Neil F. McFarlane

Insider Reports History

Entity
Individual
Location
C/O Retrophin, Inc., 12255 El Camino Real, Suite 250, San Diego, CA
Signature
/s/ Timothy J. Sangiovanni, Attorney-in-Fact for Neil F. McFarlane
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Neil F. McFarlane:

Stock Role Class Num Shares Value Price $ Report Date Ownership
COLLEGIUM PHARMACEUTICAL, INC Director Common Stock 49.4K $1.59M $32.30 May 16, 2024 Direct
ZEVRA THERAPEUTICS, INC. President and CEO, Director Common Stock 192K $1.54M $8.05 Feb 14, 2025 Direct
ZEVRA THERAPEUTICS, INC. President and CEO, Director Restricted Stock Unit 113K $890K $7.92 Feb 7, 2025 Direct
ZEVRA THERAPEUTICS, INC. President and CEO, Director Stock Option (right to buy) 225K Feb 7, 2025 Direct
Adamas Pharmaceuticals Inc Chief Executive Officer, Director Common Stock 0 $5.16 Nov 24, 2021 Direct
Adamas Pharmaceuticals Inc Chief Executive Officer, Director Stock Option (Right to Buy) 0 Nov 24, 2021 Direct

Insider Reports Filed by Neil F. McFarlane

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ZVRA ZEVRA THERAPEUTICS, INC. Feb 13, 2025 2 -$727K 4 Feb 14, 2025 President and CEO, Director
ZVRA ZEVRA THERAPEUTICS, INC. Feb 7, 2025 2 $0 4 Feb 10, 2025 President and CEO, Director
ZVRA ZEVRA THERAPEUTICS, INC. Jan 31, 2025 2 $0 4 Feb 3, 2025 President and CEO, Director
COLL COLLEGIUM PHARMACEUTICAL, INC May 16, 2024 1 $0 4 May 16, 2024 Director
ZVRA ZEVRA THERAPEUTICS, INC. Jan 31, 2024 1 $0 4 Feb 2, 2024 President and CEO, Director
ZVRA ZEVRA THERAPEUTICS, INC. Oct 10, 2023 2 $0 4 Oct 11, 2023 President and CEO, Director
ZVRA ZEVRA THERAPEUTICS, INC. Oct 10, 2023 0 $0 3 Oct 10, 2023 President and CEO, Director
COLL COLLEGIUM PHARMACEUTICAL, INC May 18, 2023 1 $0 4 May 19, 2023 Director
COLL COLLEGIUM PHARMACEUTICAL, INC May 19, 2022 1 $0 4 May 23, 2022 Director
COLL COLLEGIUM PHARMACEUTICAL, INC Apr 6, 2022 1 $0 4 Apr 8, 2022 Director
COLL COLLEGIUM PHARMACEUTICAL, INC Apr 6, 2022 0 $0 3 Apr 8, 2022 Director
ADMS Adamas Pharmaceuticals Inc Nov 24, 2021 4 $0 4 Nov 24, 2021 Chief Executive Officer, Director